Search for Clinical Trial Results
Lymphatic Malformations - 1 Studies Found
| Status | Study |
| Completed |
Study Name: Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. Condition: Lymphatic Malformations Date: 2025-03-19 Interventions: In Stage 1: adult participants (?18 years of age) will receive dose 1 or dose 2 of alpelisib; pediatric participants (6-17 years of age) will recie |